CONDITION
Gastric Adenocarcinoma
Gastric adenocarcinoma is a type of cancer that arises from the glandular cells lining the stomach. These cells normally produce mucus and digestive fluids, but when they become cancerous, they can form masses or thicken the stomach wall in ways that interfere with normal digestion and movement of food. It occurs most commonly in older dogs, with certain breeds appearing more susceptible, and is less frequently diagnosed in cats. Owners often arrive at this page because their dog or cat has been vomiting intermittently, losing weight despite a reasonable appetite, or showing a gradual decline in energy and interest in food. These signs can develop slowly over weeks or months, and may initially be mistaken for less serious digestive upset. In some cases, the condition is discovered during investigation of anaemia or abdominal discomfort. This page explores the signals that may prompt investigation, what is happening at a tissue and cellular level, how the condition is identified through imaging and biopsy, and the range of approaches that exist—including surgery, chemotherapy, and supportive care—each with its own considerations and limitations.
Why this matters now
Gastric adenocarcinoma tends to appear in dogs over seven years of age, with the highest incidence in animals between eight and ten years old. Certain breeds including Belgian Shepherds, Rough Collies, Staffordshire Bull Terriers, and Chow Chows appear to be diagnosed more frequently, though the condition can occur in any breed. Male dogs may be affected slightly more often than females. In cats, the condition is less common and the age and breed patterns are less clearly defined.
The condition often develops slowly over several months before signs become noticeable enough to prompt investigation. Early changes in the stomach lining may cause subtle digestive disturbance that owners attribute to dietary indiscretion or minor gastritis. As the tumour grows or spreads through the stomach wall, signs typically become more persistent and the animal's condition may decline more noticeably. The rate of progression can vary considerably between individuals.
Signals & patterns
Early signals
Intermittent vomiting
Vomiting may occur sporadically, sometimes hours after eating, and may contain undigested food or frothy liquid. The pattern can be inconsistent enough that it does not initially seem linked to a single underlying cause.
Gradual weight loss
Weight may decline slowly over weeks or months, even when the animal appears to be eating reasonable amounts. The loss can be subtle at first, particularly in dogs with thick coats or cats who are not weighed regularly.
Reduced appetite or selective eating
Interest in food may wane gradually, with the animal becoming pickier or eating smaller portions than usual. Some animals will eat normally for days, then refuse food for a day or two, creating an unpredictable pattern.
Decreased energy or enthusiasm
Activity levels may drop in ways that are easy to attribute to normal ageing, such as less interest in play, shorter walks, or more time spent resting. The change is often gradual enough that it becomes the new normal before it is recognised as a shift.
Later signals
Persistent or worsening vomiting
Vomiting may become more frequent and predictable, often occurring shortly after meals. In some cases, the stomach's ability to empty becomes significantly impaired, leading to vomiting of larger volumes.
Visible abdominal discomfort
The animal may show reluctance to be touched around the abdomen, adopt a hunched posture, or seem restless and unable to settle comfortably. These signs can suggest pain or nausea.
Dark or tarry faeces
Stools may become darker or have a tar-like consistency, which can indicate digested blood from bleeding within the stomach. This sign often appears alongside other digestive disturbances.
Pronounced weakness or collapse
Advanced disease or significant internal bleeding can lead to pale gums, weakness, and in some cases episodes of collapse. These signs reflect anaemia or systemic compromise.
Click to read about the biological mechanisms
How this is usually investigated
Investigation typically begins with a detailed history of the pattern and progression of signs, followed by physical examination to assess body condition, abdominal palpation findings, and signs of anaemia or dehydration. Blood tests and imaging are used to evaluate the stomach's structure and rule out other causes of similar signs. Definitive diagnosis usually requires obtaining tissue samples from the stomach lining, either through endoscopy or surgery, which are then examined microscopically.
Blood tests (haematology and biochemistry)
Abdominal radiography
Abdominal ultrasonography
Endoscopy and biopsy
Surgical exploration and full-thickness biopsy
Options & trade-offs
Management of gastric adenocarcinoma is usually individualised, taking into account the extent of disease at diagnosis, the animal's overall health, and what is practical and acceptable for the owner. Treatment may combine surgical removal of the tumour, chemotherapy to slow progression or address spread, and supportive care to manage signs and maintain quality of life. Different combinations suit different animals, and the course may be adjusted over time as the disease evolves or as the animal's response becomes clearer.
Surgical resection
If the tumour is localised to a portion of the stomach that can be removed without compromising the organ's function, surgery may involve partial gastrectomy—removing the affected segment and reconnecting the remaining healthy tissue. In some cases, the tumour's location or extent makes complete removal technically difficult or impossible. Surgery may also be used to relieve obstruction even when the tumour cannot be fully excised.
Trade-offs: Surgery carries risks associated with anaesthesia, the technical demands of abdominal surgery, and the potential for complications such as leakage at the surgical site or delayed healing. Even when the visible tumour is removed, microscopic spread to lymph nodes or other sites may already be present, and recurrence is common. Recovery requires careful nutritional management and monitoring.
Chemotherapy
Chemotherapy uses drugs that interfere with the growth and division of cancer cells. It is sometimes used after surgery to address microscopic disease, or as the primary treatment when surgery is not feasible due to the tumour's extent or the animal's health. Protocols vary and may involve single agents or combinations given over several weeks to months.
Trade-offs: Response rates to chemotherapy in gastric adenocarcinoma tend to be modest, and the disease often continues to progress, though the rate may be slowed in some individuals. Side effects can include nausea, reduced appetite, and suppression of bone marrow function, which requires monitoring. The time and financial commitment can be considerable.
Supportive and palliative care
Supportive care focuses on managing signs such as nausea, vomiting, pain, and poor appetite, and on maintaining hydration and nutritional intake. This may involve medications to reduce stomach acid, control nausea, protect the stomach lining, and manage pain, along with dietary adjustments to provide easily digestible, palatable food. Some animals benefit from appetite stimulants or temporary feeding tubes if oral intake becomes inadequate.
Trade-offs: Supportive care does not alter the progression of the tumour itself, but can improve comfort and quality of life for a period of time. The duration of benefit varies widely, and the condition typically continues to advance. This approach is often chosen when surgery or chemotherapy are declined, not tolerated, or when the disease is too advanced for other interventions to be practical.
Combination approaches
Many animals receive a combination of surgery, chemotherapy, and supportive care, tailored to their individual circumstances. For example, surgery may be followed by chemotherapy and ongoing medication to manage digestive signs. The combination and sequence are adjusted based on how the animal responds, changes in disease extent, and the owner's priorities and resources over time.
Trade-offs: Combining approaches can offer the potential for longer control of disease or better quality of life than any single intervention alone, but also increases complexity, cost, and the demands on the owner and animal. Coordination between different aspects of care requires clear communication and often frequent reassessment.
Common misconceptions
"If the tumour is removed surgically, the cancer is cured and will not return."
Gastric adenocarcinoma often spreads microscopically beyond the visible tumour margins or to nearby lymph nodes and organs before diagnosis. Even when the primary tumour is successfully removed, recurrence at the surgical site or progression of disease elsewhere in the body is common. Surgery can extend the time an animal feels well, but it does not guarantee a cure.
"Chemotherapy in animals works the same way as in people and will make the pet very ill."
Chemotherapy protocols in veterinary medicine are generally designed to minimise severe side effects, and many animals tolerate treatment without significant illness. Nausea, reduced appetite, and mild lethargy can occur, but severe reactions are less common. The goal is often to slow disease progression while maintaining quality of life, rather than to achieve cure at any cost.
"Changing the diet or using supplements can stop the tumour from growing."
While good nutrition is important for maintaining strength and supporting recovery from treatment, there is no diet or supplement that has been shown to halt the progression of gastric adenocarcinoma. Dietary adjustments can help manage signs such as nausea and poor appetite, and may improve comfort, but they do not treat the underlying cancer.
Related conditions
Intestinal Adenocarcinoma
Intestinal adenocarcinoma arises from the same type of glandular cells as gastric adenocarcinoma, but in a different segment of the digestive tract. The signs, diagnostic approach, and treatment considerations often overlap, though the location of the tumour influences which symptoms appear first and which surgical options may be feasible.
Gastric Ulceration
Gastric ulceration can occur alongside gastric adenocarcinoma, either as a consequence of the tumour eroding through the stomach lining or as a separate process that shares similar signs—vomiting, weight loss, and anaemia. Distinguishing between ulceration and underlying cancer often requires biopsy, as imaging alone may not clarify whether a mass or thickening is present beneath the ulcerated surface.
Alimentary Lymphoma in Cats
Alimentary lymphoma in cats can present with a similar clinical picture to gastric adenocarcinoma—chronic vomiting, weight loss, and thickening of the gastrointestinal wall on imaging. In cats with persistent digestive signs, both conditions may be considered during investigation, and biopsy is typically needed to distinguish between the two.
Chronic Pancreatitis
Chronic pancreatitis can produce overlapping signs with gastric adenocarcinoma, including vomiting, reduced appetite, and gradual weight loss. In some cases, inflammation in the pancreas and changes in the stomach may coexist, particularly in cats, where digestive organs are anatomically close and inflammation in one area can influence another.
Helicobacter Gastritis
Helicobacter bacteria can colonise the stomach lining and contribute to chronic inflammation, and there has been interest in whether long-standing gastritis may, in some cases, precede the development of gastric tumours. While the relationship remains under study, both conditions involve changes to the gastric mucosa and may prompt investigation when vomiting or digestive upset persists.
Animals with gastric adenocarcinoma may also be at risk for other age-related conditions that affect digestion, circulation, or organ function, and understanding how these interact can be useful. The Longevity & Healthspan pillar offers broader context on how different body systems change over time and how those changes may influence the course of illness and recovery. As the picture becomes clearer through investigation, there may be value in exploring what quality of life means in practical terms for a given animal, and what markers of comfort and function are most meaningful to observe over time.